Jardiance Tablets Review: The Modern Ally in Type 2 Diabetes Management

1. What is Jardiance Tablets?
Jardiance Tablets, generically known as Empagliflozin, is an oral antidiabetic medication that belongs to a class called SGLT2 inhibitors (Sodium-Glucose Co-Transporter 2 inhibitors). Manufactured by Boehringer Ingelheim and Eli Lilly, it has rapidly gained recognition due to its unique triple-action benefits — blood sugar regulation, cardiovascular protection, and kidney health improvement.
Available in 10 mg and 25 mg tablet forms, Jardiance is FDA-approved and recommended by major diabetes associations globally. Unlike traditional medications that solely focus on insulin production or resistance, Jardiance offers a holistic approach to managing the complexities of Type 2 Diabetes.
________________________________________
2. How Jardiance Works
To understand the brilliance of Jardiance, one must look at its mechanism of action. The primary function of Empagliflozin is to block the SGLT2 protein in the kidneys, which is responsible for reabsorbing glucose back into the blood. By inhibiting this protein, Jardiance prompts the kidneys to excrete excess glucose through urine.
But that’s just the beginning. This mechanism not only lowers blood sugar levels but also contributes to:
• Lower blood pressure due to diuretic effects
• Reduced body weight through calorie loss
• Improved cardiovascular outcomes by easing the workload on the heart
This multi-dimensional approach makes Jardiance stand out among its peers.